Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan Faces Double Threat To Blockbuster Drug Tysabri
Elan Faces Double Threat To Blockbuster Drug Tysabri
Elan Faces Double Threat To Blockbuster Drug Tysabri
Submitted by
admin
on June 17, 2010 - 11:32am
Source:
WSJ
News Tags:
Elan
MS
Tysabri
Biogen Idec
Novartis
Gilenia
Headline:
Elan Faces Double Threat To Blockbuster Drug Tysabri
Do Not Allow Advertisers to Use My Personal information
